Business Context and Reporting Period
This summary covers the Form 10-Q filed by Torchmark Corporation (parent of Globe Life Inc.) for the quarter and nine months ended September 30, 2007. Torchmark is a life and health insurance company marketing primarily individual life and supplemental health products through niche distribution systems to middle-income Americans. The company also manages a significant investment portfolio to support its insurance liabilities.
Key Financial Metrics (Nine Months Ended Sept 30, 2007)
| Metric | 2007 (9 Months) | 2006 (9 Months) |
|---|---|---|
| Total Revenue | $2,646 million | $2,564 million |
| Net Income | $395 million | $376 million |
| Diluted EPS | $4.09 | $3.70 |
| Net Investment Income | $486 million | $469 million |
| Excess Investment Income | $244 million | $239 million |
| Total Assets | $15.15 billion | $14.98 billion (Dec 31, 2006) |
| Total Liabilities | $11.89 billion | $11.52 billion (Dec 31, 2006) |
| Shareholders' Equity | $3.26 billion | $3.46 billion (Dec 31, 2006) |
| Long-Term Debt (Book Value) | $598 million | $598 million (Dec 31, 2006) |
| Short-Term Debt | $204 million | $170 million (Dec 31, 2006) |
| Cash Flow from Operations | $655 million | $676 million |
Material Changes vs. Prior Period
- Profitability: Net income increased 5% to $395 million, driven by a 5% increase in life insurance underwriting margins and a 2% increase in health insurance underwriting margins. Diluted EPS rose 11% to $4.09.
- Revenue Growth: Total premium income rose 2% to $2.14 billion. Life premiums increased 3%, while health premiums (excluding Medicare Part D) increased 1%.
- Investment Performance: Net investment income grew 4% to $486 million. However, the average portfolio yield declined slightly as new investments were made at lower rates (6.72% effective yield on new acquisitions vs. 6.96% portfolio average).
- Share Repurchases: The company repurchased 6.9 million shares of common stock for $448 million during the nine-month period, significantly reducing the share count.
- Equity Volatility: Shareholders' equity decreased by approximately $200 million from year-end 2006, primarily due to $401 million in share repurchases and $168 million in unrealized after-tax losses on the fixed-maturity portfolio due to rising interest rates.
- Acquisition: In January 2007, the company acquired Direct Marketing and Advertising Distributors, Inc. (DMAD) for $47 million to enhance its direct response distribution capabilities.
Guidance, Outlook, and Risks
- Management Outlook: Management expects the acquisition of DMAD to result in increased distribution opportunities and reduced acquisition costs. They anticipate continued growth in limited-benefit health products but do not expect significant growth in Medicare Part D enrollees following the initial launch year.
- Interest Rate Environment: Excess investment income remains restricted as short-term financing costs are high while long-term investment yields have not increased significantly. Management notes that higher long-term rates on new investments would benefit excess income more than a decline in short-term borrowing rates.
- Key Risks:
- Regulatory Changes: Potential changes to the Federal Medicare program could impact Medicare Supplement and Part D business.
- Interest Rate Risk: Fluctuations in interest rates affect investment portfolio yields and the fair value of assets, causing volatility in reported shareholders' equity under SFAS 115.
- Legal Proceedings: Ongoing litigation in Alabama regarding cancer policies (Roberts v. Liberty National) remains a risk, though a settlement agreement was recently reinstated by the Alabama Supreme Court.
- Mortality and Morbidity: Unexpected changes in lapse rates, mortality, or healthcare utilization could adversely affect results.
- Unusual Items: Net income included $5.6 million in after-tax realized investment gains in 2007, compared to $3.9 million in losses in 2006. Management excludes these from core operating results as they are incidental to insurance operations.
Investor Verification Checklist
- Share Count Impact: Verify the impact of the $448 million share repurchase program on future earnings per share and capital structure.
- Investment Yield Trend: Monitor the spread between the average portfolio yield (6.96%) and the yield on new investments (6.72%) to assess future investment income growth.
- Medicare Part D Margins: Review the reconciliation between GAAP and segment reporting for Medicare Part D, specifically the deferral of excess benefits to match revenue.
- Legal Settlement Status: Track the implementation of the settlement agreement in the Alabama cancer policy litigation.
- Equity Volatility: Understand that reported shareholders' equity is significantly impacted by unrealized gains/losses on fixed maturities (SFAS 115) and does not reflect the fair value of policy liabilities.